KYRNF vs AAPL: Which Stock is Better?
Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Apple Inc in 2026
KYRNF
KYORIN Pharmaceutical Co., Ltd.
$10.31
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | KYRNF | AAPL | Winner |
|---|---|---|---|
| Market Cap | $592.33M | N/A | KYRNF |
| P/E Ratio | 10.11 | 33.32 | KYRNF |
| EPS (TTM) | $1.02 | $8.11 | AAPL |
| Revenue Growth | -0.0% | 0.2% | AAPL |
| Gross Margin | 45.3% | 47.3% | AAPL |
Analyze KYRNF
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYRNF or AAPL a better investment?
Comparing KYRNF and AAPL: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYRNF and AAPL?
KYRNF (KYORIN Pharmaceutical Co., Ltd.) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYRNF or AAPL?
Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 33.3x).
Which is growing faster: KYRNF or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.0% for KYRNF.
Which company is more profitable: KYRNF or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 45.3% for KYRNF.
Which is the larger company: KYRNF or AAPL?
KYORIN Pharmaceutical Co., Ltd. (KYRNF) is larger with a market cap of $592.33M compared to N/A for AAPL.
Should I buy KYRNF or AAPL in 2026?
Both KYRNF and AAPL have investment merit. KYRNF trades at $10.31 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYRNF and AAPL stock?
Key differences: Market Cap ($592.33M vs N/A), P/E Ratio (10.1x vs 33.3x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (45.3% vs 47.3%).